-
1
-
-
0038412561
-
Normal-release and controlled-release oxycodone: Pharmacokinetics, pharmacodynamics, and controversy
-
12560936
-
Davis MP Varga J Dickerson D Walsh D LeGrand SB Lagman R Normal-release and controlled-release oxycodone: Pharmacokinetics, pharmacodynamics, and controversy Support Care Cancer 2003, 11(2):84-92 12560936
-
(2003)
Support Care Cancer
, vol.11
, Issue.2
, pp. 84-92
-
-
Davis, M.P.1
Varga, J.2
Dickerson, D.3
Walsh, D.4
LeGrand, S.B.5
Lagman, R.6
-
2
-
-
0018765590
-
Determination of oxycodone in plasma and identification of a major metabolite
-
10.1002/jps.2600680441 35601
-
Weinstein SH Gaylord JC Determination of oxycodone in plasma and identification of a major metabolite J Pharm Sci 1979, 68(4):527-528 10.1002/jps.2600680441 35601
-
(1979)
J Pharm Sci
, vol.68
, Issue.4
, pp. 527-528
-
-
Weinstein, S.H.1
Gaylord, J.C.2
-
3
-
-
0031952421
-
Open-label trial of oral nalmefene therapy for the pruritus of cholestasis
-
10.1002/hep.510270307 9500694
-
Bergasa NV Schmitt JM Talbot TL Alling DW Swain MG Turner ML Jenkins JB Jones EA Open-label trial of oral nalmefene therapy for the pruritus of cholestasis Hepatology 1998, 27(3):679-684 10.1002/hep.510270307 9500694
-
(1998)
Hepatology
, vol.27
, Issue.3
, pp. 679-684
-
-
Bergasa, N.V.1
Schmitt, J.M.2
Talbot, T.L.3
Alling, D.W.4
Swain, M.G.5
Turner, M.L.6
Jenkins, J.B.7
Jones, E.A.8
-
4
-
-
0024211842
-
Opioid peptides and primary biliary cirrhosis
-
1835218 3147046
-
Thornton JR Losowsky MS Opioid peptides and primary biliary cirrhosis BMJ 1988, 297(6662):1501-1504 1835218 3147046
-
(1988)
BMJ
, vol.297
, Issue.6662
, pp. 1501-1504
-
-
Thornton, J.R.1
Losowsky, M.S.2
-
5
-
-
0029859359
-
Hepatic concentrations of proenkephalin-derived opioids are increased in a rat model of cholestasis
-
8938629
-
Bergasa NV Vergalla J Swain MG Jones EA Hepatic concentrations of proenkephalin-derived opioids are increased in a rat model of cholestasis Liver 1996, 16(5):298-302 8938629
-
(1996)
Liver
, vol.16
, Issue.5
, pp. 298-302
-
-
Bergasa, N.V.1
Vergalla, J.2
Swain, M.G.3
Jones, E.A.4
-
6
-
-
0026718627
-
Central mu-opioid receptors are down regulated in a rat model of cholestasis
-
10.1016/0168-8278(92)90040-V 1324272
-
Bergasa NV Rothman RB Vergalla J Xu H Swain MG Jones EA Central mu-opioid receptors are down regulated in a rat model of cholestasis J Hepatol 1992, 15(1-2):220-224 10.1016/0168-8278(92)90040-V 1324272
-
(1992)
J Hepatol
, vol.15
, Issue.1-2
, pp. 220-224
-
-
Bergasa, N.V.1
Rothman, R.B.2
Vergalla, J.3
Xu, H.4
Swain, M.G.5
Jones, E.A.6
-
7
-
-
27744535986
-
The pruritus of cholestasis
-
16253381
-
Bergasa NV The pruritus of cholestasis J Hepatol 2005, 43(6):1078-1088 16253381
-
(2005)
J Hepatol
, vol.43
, Issue.6
, pp. 1078-1088
-
-
Bergasa, N.V.1
-
9
-
-
0019799332
-
A method for estimating the probability of adverse drug reactions
-
7249508
-
Naranjo CA Busto U Sellers EM Sandor P Ruiz I Roberts EA Janecek E Domecq C Greenblatt DJ A method for estimating the probability of adverse drug reactions Clin Pharmacol Ther 1981, 30(2):239-45 7249508
-
(1981)
Clin Pharmacol Ther
, vol.30
, Issue.2
, pp. 239-245
-
-
Naranjo, C.A.1
Busto, U.2
Sellers, E.M.3
Sandor, P.4
Ruiz, I.5
Roberts, E.A.6
Janecek, E.7
Domecq, C.8
Greenblatt, D.J.9
-
10
-
-
0027362542
-
Causality assessment of adverse reactions to drugs. I. A novel method based on the conclusions of international consensus meetings: Application to drug-induced liver injuries
-
10.1016/0895-4356(93)90101-6 8229110
-
Danan G Bénichou C Causality assessment of adverse reactions to drugs. I. A novel method based on the conclusions of international consensus meetings: Application to drug-induced liver injuries J Clin Epidemiol 1993, 46(11):1323-1330 10.1016/0895-4356(93)90101-6 8229110
-
(1993)
J Clin Epidemiol
, vol.46
, Issue.11
, pp. 1323-1330
-
-
Danan, G.1
Bénichou, C.2
|